These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2647471)
21. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat. Lumpkin MD; Samson WK; McCann SM Endocrinology; 1983 May; 112(5):1711-7. PubMed ID: 6403333 [TBL] [Abstract][Full Text] [Related]
22. Sodium ions: their role and mechanism of action in the control of prolactin release. Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371 [TBL] [Abstract][Full Text] [Related]
23. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine. Luque EH; Munoz de Toro M; Smith PF; Neill JD Endocrinology; 1986 May; 118(5):2120-4. PubMed ID: 3084212 [TBL] [Abstract][Full Text] [Related]
24. Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary. Cheung CY Endocrinology; 1983 Aug; 113(2):632-8. PubMed ID: 6347662 [TBL] [Abstract][Full Text] [Related]
25. Stimulation of growth hormone and prolactin release from rat pituitary cell aggregates by bombesin- and ranatensin-like peptides is potentiated by estradiol, 5 alpha-dihydrotestosterone, and dexamethasone. Houben H; Denef C Endocrinology; 1990 May; 126(5):2257-66. PubMed ID: 2328688 [TBL] [Abstract][Full Text] [Related]
26. Detection of prolactin inhibitory activity in uterine epithelial cell secretions and rat serum. Gorospe WC; Freeman ME Endocrinology; 1985 Apr; 116(4):1559-64. PubMed ID: 3971927 [TBL] [Abstract][Full Text] [Related]
27. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061 [TBL] [Abstract][Full Text] [Related]
28. Pituitaries transplanted under the renal capsule contain functional growth hormone (GH) secretors and suppress GH and prolactin release from individual eutopic pituitary cells. Porter TE; Chen TT; Frawley LS Endocrinology; 1989 Dec; 125(6):3059-67. PubMed ID: 2510989 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin II receptors and prolactin release in pituitary lactotrophs. Aguilera G; Hyde CL; Catt KJ Endocrinology; 1982 Oct; 111(4):1045-50. PubMed ID: 6288343 [TBL] [Abstract][Full Text] [Related]
30. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+. Shah GV; Wang W; Grosvenor CE; Crowley WR Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431 [TBL] [Abstract][Full Text] [Related]
31. Ontogeny of prolactin cells in neonatal rats: initial prolactin secretors also release growth hormone. Hoeffler JP; Boockfor FR; Frawley LS Endocrinology; 1985 Jul; 117(1):187-95. PubMed ID: 3891313 [TBL] [Abstract][Full Text] [Related]
33. Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro. Camoratto AM; Grandison L Endocrinology; 1989 Mar; 124(3):1502-6. PubMed ID: 2917522 [TBL] [Abstract][Full Text] [Related]
34. The effect of relaxin infusion on prolactin and growth hormone secretion in monkeys. Bethea CL; Cronin MJ; Haluska GJ; Novy MJ J Clin Endocrinol Metab; 1989 Nov; 69(5):956-62. PubMed ID: 2793997 [TBL] [Abstract][Full Text] [Related]
35. In vivo and in vitro effects of cholecystokinin octapeptide on the release of prolactin in rats. Matsumura M; Yamanoi A; Yamamoto S; Mori H; Saito S Horm Metab Res; 1985 Jun; 17(6):293-7. PubMed ID: 4018718 [TBL] [Abstract][Full Text] [Related]
36. Low concentrations of dopamine increase cytosolic calcium in lactotrophs. Burris TP; Freeman ME Endocrinology; 1993 Jul; 133(1):63-8. PubMed ID: 8391429 [TBL] [Abstract][Full Text] [Related]
37. Identification by plaque assays of a pituitary cell type that secretes both growth hormone and prolactin. Frawley LS; Boockfor FR; Hoeffler JP Endocrinology; 1985 Feb; 116(2):734-7. PubMed ID: 3881246 [TBL] [Abstract][Full Text] [Related]
38. Paracrine cell to cell interactions determine the effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vitro prolactin release from rat pituitary cells. Benter S; Leonhardt S; Wuttke W; Jarry H Exp Clin Endocrinol Diabetes; 1995; 103(6):386-90. PubMed ID: 8788312 [TBL] [Abstract][Full Text] [Related]
39. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization. Schettini G; Cronin MJ; MacLeod RM Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710 [TBL] [Abstract][Full Text] [Related]
40. Detection of hormone release from individual cells in mixed populations using a reverse hemolytic plaque assay. Neill JD; Frawley LS Endocrinology; 1983 Mar; 112(3):1135-7. PubMed ID: 6401620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]